Global Anastrozole Tablets Market Top Leading Players with Strategies and Forecast 2028

The global anastrozole tablets market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Rising incidence of breast cancer among the population across the globe is primary factor contributing towards the growth of the market. Anastrozole tablets are primarly used to used for hormone receptor-positive breast cancer. It is also been used to prevent breast cancer in women which are at high risk of menopause. According to the World Health Organization's (WHO) list of essential Medicines, anastrozole is the safest and most effective medicine for breast cancer in menopausal women. As of 2021, according to  the WHO, around one in twenty-eight Indian women is likely to develop breast cancer. Moreover, one in twenty-two of urban women compared to rural group which is one in sixty women. Anastrozole belongs to the aromatase-inhibiting drug class.
 
Another factor propelling the growth of the market is the increasing product launches from key market players such as Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., AstraZeneca Plc, and other. For instance, in July 2020, Aurobindo Pharma Ltd., received the US FDA approval for Anastrozole Tablets USP, 1 mg. Furthermore, in September 2019, Cooper Pharma launched ANAZBOL, which is anastrozole tablets in New Delhi, India, to treat breast cancer in women who have gone through menopause. Additionally, in December 2019, Juvise Pharmaceuticals completed the acquisition of AstraZeneca Plc's commercial rights to Arimidex (anastrozole) and Casodex (bicalutamide) across the European, African, and other 40 countries. Juvisé Pharmaceuticals entered the cancer therapeutic field with this acquisition, where the business aims to extend and consolidate its growing ambition.

(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Anastrozole Tablets Market at https://orionmarketreports.com/request-sample/?id=92681&submit=Request+Sample%0D%0A

Market Coverage
The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Distribution Channel
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
 Competitive Landscape- AstraZeneca plc, Zydus Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Natco Pharma Ltd, Dr. Reddy's Laboratories, among others.

A full report is available at: https://orionmarketreports.com/global-anastrozole-tablets-market/92681/
 

Global Anastrozole Tablets Market Report by Segment
By Type
Branded Anastrozole Tablets
Generic Anastrozole Tablets

By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.